210. Single Ventricle Clinical trials / Disease details
Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00113087 (ClinicalTrials.gov) | August 2003 | 3/6/2005 | Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network | Trial of ACE Inhibition in Infants With Single Ventricle (A Trial Conducted by the Pediatric Heart Network) | Heart Defects, Congenital;Heart Failure, Congestive | Drug: Enalapril;Drug: Placebo | National Heart, Lung, and Blood Institute (NHLBI) | Pediatric Heart Network | Completed | N/A | 45 Days | All | 230 | Phase 3 | United States;Canada |